阿尔法陶医疗

最新新闻

• 评级变动
  H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/4/25
• 评级变动
  Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• 评级变动
  H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  H.C. Wainwright Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)
  TipRanks · 2025/12/4
• 评级变动
  Ladenburg Thalmann Initiates Alpha Tau Medical(DRTS.US) With Buy Rating, Announces Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 评级变动
  Piper Sandler Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/11/21
• Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/9/1
• 评级变动
  Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $8
  \u5e02\u573a\u8d44\u8baf · 2025/8/13
• 评级变动
  H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9
  \u5e02\u573a\u8d44\u8baf · 2026/1/13
• 评级变动
  Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $9
  \u5e02\u573a\u8d44\u8baf · 2026/3/11
• 评级变动
  H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2026/2/25
• Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/9/3
• 评级变动
  Citi Initiates Alpha Tau Medical(DRTS.US) With Buy Rating, Announces Target Price $8
  \u5e02\u573a\u8d44\u8baf · 2024/11/15
• 评级变动
  Piper Sandler Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Cuts Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2024/11/20
• 评级变动
  H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• 评级变动
  Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Cuts Target Price to $7
  \u5e02\u573a\u8d44\u8baf · 2025/12/10

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。